Cargando…
Liposomes in Cancer Therapy: How Did We Start and Where Are We Now
Since their first discovery in the 1960s by Alec Bangham, liposomes have been shown to be effective drug delivery systems for treating various cancers. Several liposome-based formulations received approval by the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA), with many...
Autores principales: | Fulton, Melody D., Najahi-Missaoui, Wided |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095497/ https://www.ncbi.nlm.nih.gov/pubmed/37047585 http://dx.doi.org/10.3390/ijms24076615 |
Ejemplares similares
-
Acute promyelocytic leukemia: where did we start, where are we now, and the future
por: Coombs, C C, et al.
Publicado: (2015) -
Safe Nanoparticles: Are We There Yet?
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020) -
The deep inferior epigastric perforator flap: where we started and where we are now
por: Nahabedian, Maurice Y.
Publicado: (2023) -
Interventional oncology of liver tumors: how it all started and where are we now
por: Solbiati, Luigi A., et al.
Publicado: (2022) -
Targeting therapy in pemphigus: Where are we now and where are we going?
por: Abulikemu, Kailibinuer, et al.
Publicado: (2023)